The resistance phenotype in the development and treatment of cancer
Authors:
- Ezio LaconiELEzio Laconi
- Paolo PaniPPPaolo Pani
- Emmanuel FarberEFEmmanuel Farber
- 1 December 2000
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 1 (4) , 235-241
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Genetic and Epigenetic Factors in Anticancer Drug ResistanceJNCI: Journal of the National Cancer Institute, 2000
- Cytotoxic drugs and the CD95 pathwayLeukemia, 1999
- A multidrug resistance transporter from human MCF-7 breast cancer cellsProceedings of the National Academy of Sciences, 1998
- The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancerBritish Journal of Cancer, 1997
- MDR1 gene expression in solid tumoursEuropean Journal of Cancer, 1996
- Antitopoisomerase drug action and resistanceEuropean Journal of Cancer, 1996
- The drug resistance-related protein LRP is the human major vault proteinNature Medicine, 1995
- Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell LineScience, 1992
- A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutantsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1976
- New principle for the analysis of chemical carcinogenesisNature, 1976